Eosinophils elicit proliferation of naive and fungal-specific cells in vivo so enhancing a T helper type 1 cytokine profile in favour of a protective immune response against Cryptococcus neoformans infection

Immunology

Volumn 134, Issue 2, 2011, Pages 198-213

  Garro, Ana P ^a   Chiapello, Laura S ^a   Baronetti, Jose L ^a   Masih, Diana T ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Antigen presentation; Cryptococcus neoformans; Eosinophils; T helper type 1 profile

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; FUNGUS ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; EOSINOPHIL; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IN VITRO STUDY; INTERFERON PRODUCTION; LYMPHOID ORGAN; MALE; MICROENVIRONMENT; NONHUMAN; OPSONIZATION; PERITONEUM CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; SYNTHESIS; TH1 CELL; UPREGULATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, FUNGAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; COCULTURE TECHNIQUES; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; EOSINOPHILS; INTERFERON-GAMMA; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MALE; NITRIC OXIDE; RATS; RATS, WISTAR; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052443985     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03479.x     Document Type: Article

References (52)

1. Perfect JR, Casadevall A. Cryptococcosis. Infect Dis Clin North Am 2002; 16:837-74.
2. Feldmesser M, Kress Y, Novikoff P, Casadevall A. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 2000; 68:4225-37.
3. Goldman D, Lee SC, Casadevall A. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun 1994; 62:4755-61.
4. Kobayashi M, Ito M, Sano K, Koyama M. Granulomatous and cytokine responses to pulmonary Cryptococcus neoformans in two strains of rats. Mycopathologia 2001; 151:121-30.
5. Chensue SW, Warmington KS, Ruth JH, Lincoln P, Kunkel SL. Cytokine function during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation: local and regional participation of IFN-γ, IL-10, and TNF. J Immunol 1995; 154:5969-76.
6. Chensue SW, Ruth JH, Warmington K, Lincoln P, Kunkel SL. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. J Immunol 1995; 155:3546-51.
7. Chensue SW, Warmington K, Ruth JH, Lukacs N, Kunkel SL. Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-γ and IL-4 knockout mice. J Immunol 1997; 159:3565-73.
8. + T cells. J Exp Med 1991; 173:793-800.
9. Huffnagle GB, Toews GB, Burdick MD et al. Afferent phase production of TNF-α is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol 1996; 157:4529-36.
10. Abe K, Kadota J, Ishimatsu Y et al. Th1-Th2 cytokine kinetics in the bronchoalveolar lavage fluid of mice infected with Cryptococcus neoformans of different virulences. Microbiol Immunol 2000; 44:849-55.
11. Lovchik JA, Wilder JA, Huffnagle GB, Riblet R, Lyons CR, Lipscomb MF. Ig heavy chain complex-linked genes influence the immune response in a murine cryptococcal infection. J Immunol 1999; 163:3907-13.
12. Hoag KA, Street NE, Huffnagle GB, Lipscomb MF. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am J Respir Cell Mol Biol 1995; 13:487-95.
13. Murphy JW, Bistoni F, Deepe GS et al. Type 1 and type 2 cytokines: from basic science to fungal infections. Med Mycol 1998; 36:109-18.
14. Jung Y-J, Woo S-Y, Jang MH, Miyasaka M, Ryu K-H, Park H-K, Seoh J-Y. Human eosinophils show chemotaxis to lymphoid chemokines and exhibit antigen presenting cell-like properties upon stimulation with IFN-γ, IL-3 and GM-CSF. Int Arch Allergy Immunol 2008; 146:227-34.
15. Butterworth AE. The eosinophil and its role in immunity to helminth infection. Curr Top Microbiol Immunol 1977; 77:127-68.
16. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006; 24:147-74.
17. + Th2 lymphocyte function. J Immunol 2001; 167:3146-55.
18. Xie ZF, Shi HZ, Qin XJ, Kang LF, Huang CP, Chen YQ. Effects of antigen presentation of eosinophils on lung Th1/Th2 imbalance. Chin Med J 2005; 118:6-11.
19. Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 2000; 105:945-53.
20. Shi HZ. Eosinophils function as antigen-presenting cells. J Leukoc Biol 2004; 76:520-7.
21. Padigel UM, Lee JJ, Nolan TJ, Schad GA, Abraham D. Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis. Infect Immun 2006; 74:3232-8.
22. Padigel UM, Hess JA, Lee JJ et al. Eosinophils act as antigen-presenting cells to induce immunity to Strongyloides stercoralis in mice. J Infect Dis 2007; 196:1844-51.
23. + T cells with a Th1 profile. Immunology 2010; 132:174-87.
24. Duez C, Dakhama A, Tomkinson A, Marquillies P, Balhorn A, Tonnel AB, Bratton DL, Gelfand EW. Migration and accumulation of eosinophils toward regional lymph nodes after airway allergen challenge. J Allergy Clin Immunol 2004; 114:820-5.
25. Jose PJ, Griffiths-Johnson DA, Collins PD et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994; 179:881-7.
26. Ponath PD, Qin S, Ringler DJ et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996; 97:604-12.
27. Rossi GR, Cervi LA, Garcia MM, Chiapello LS, Sastre DA, Masih DT. Involvement of nitric oxide in protecting mechanism during experimental cryptococcosis. Clin Immunol 1999; 90:256-65.
28. Chiapello L, Iribarren P, Cervi L, Rubinstein H, Masih DT. Mechanisms for induction of immunosuppression during experimental cryptococcosis. Role of glucuronoxylomannan. Clin Immunol 2001; 100:96-106.
29. Chiapello LS, Aoki MP, Rubinstein HR, Masih DT. Apoptosis induction by glucuronoxylomannan of Cryptococcus neoformans. Med Mycol 2003; 41:347-53.
30. Chiapello LS, Baronetti JL, Aoki MP, Rubinstein HR, Masih DT. Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan. Immunology 2004; 113:392-400.
31. Chiapello LS, Baronetti JL, Garro AP, Spesso MF, Masih DT. Cryptococcus neoformans glucuronoxylomannan induces macrophage apoptosis mediated by nitric oxide in a caspase-independent pathway. Int Immun 2008; 20:1527-41.
32. Sedgwick JB, Shikama Y, Nagata M, Brener K, Busse WW. Effect of isolation protocol on eosinophil function: percoll gradients versus immunomagnetic beads. J Immunol Methods 1996; 198:15-24.
33. Parish CR, Warren HS. Use of intracellular fluorescent dye CFSE to monitor lymphocytes migration and proliferation. Curr Protoc Immunol 2001; 9:1-10.
34. Rubinstein HR, Sotomayor CE, Cervi LA, Riera CM, Masih DT. Immunosuppression in experimental cryptococcosis in rats: modification of macrophage functions by T suppressor cells. Macrophages functions in cryptococcosis. Mycopathologia 1989; 108:11-19.
35. Rytömma T. Organ distribution and histochemical properties of eosinophil granulocytes in the rat. Acta Pathol Microbiol Scand 1960; 50:1-118.
36. Wang HB, Ghiran I, Matthaei K, Weller PF. Airway eosinophils: allergic inflammation recruited professional antigen presenting cells. J Immunol 2007; 179:7585-92.
37. Yamamoto H, Sedgwick JB, Vrtis RF, Busse WW. The effect of transendothelial migration on eosinophil function. Am J Respir Cell Mol Biol 2000; 23:379-88.
38. Kawakami K, Qifeng X, Tohyama M, Qureshi MH, Saito A. Contribution of tumor necrosis factor-alfa (TNFα) in host defence mechanism against Cryptococcus neoformans. Clin Exp Immunol 1996; 106:468-74.
39. Aguirre K, Havell EA, Gibson GW, Johnson LL. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun 1995; 63:1725-31.
40. Hoag KA, Lipscomb MF, Izzo AA, Street NE. IL-12 and IFN-γ are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am J Respir Cell Mol Biol 1997; 17:733-9.
41. Chen GH, McNamara DA, Hernandez Y, Huffnagle GB, Toews GB, Olszewski MA. Inheritance of immune polarization patterns is linked to resistance versus susceptibility to Cryptococcus neoformans in a mouse model. Infect Immun 2008; 76:2379-91.
42. Hernandez Y, Arora S, Erb-Downward JR, McDonald RA, Toews GB, Huffnagle GB. Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J Immunol 2005; 174:1027-36.
43. + T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol 1994; 55:35-42.
44. Aguirre KM, Gibson GW. Differing requirement for inducible nitric oxide synthase activity in clearance of primary and secondary Cryptococcus neoformans infection. Med Mycol 2000; 38:343-53.
45. Beenhouwer DO, Shapiro S, Felmesser M, Casadevall A, Scharff MD. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Infect Immun 2001; 69:6445-55.
46. Wormley FL Jr, Perfect JR, Steele Ch, Cox GM. Protection against Cryptococcosis by using a murine gamma Interferon-producing Cryptococcus neoformans strain. Infect Immun 2007; 75:1453-62.
47. Williams AE, Humphreys IR, Cornere M, Edwards L, Rae A, Hussel T. TGF-beta prevents eosinophilic lung disease but impairs pathogen clearance. Microbes Infect 2005; 7:365-74.
48. Adams DH, Hathaway M, Shaw J, Burnett D, Elias E, Strain AJ. Transforming growth factor-beta induces human T lymphocyte migration in vitro. J Immunol 1991; 147:609-12.
49. Buckley CD, Amft N, Bradfield PF et al. Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol 2000; 165:3423-9.
50. +) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med 2002; 196:517-27.
51. Benham RW. Cryptococci-their identification by morphology and by serology. J Infect Dis 1935; 57:255-74.
52. Goldman DL, Davis J, Bommarito F, Shao X, Casadevall A. Enhanced allergic inflammation and airway responsiveness in rats with chronic Cryptococcus neoformans infection: potential role for fungal pulmonary infection in the pathogenesis of asthma. J Infect Dis 2006; 193:1178-86.